Home

Comorbidity

Read time: 2 min

Congress highlights

Impact of abuse on migraine symptoms and comorbidity

Emotional, physical, and sexual abuse are associated with an increased risk for developing migraine...

Read time: 3 min

Satellite symposium

The metabolic interplay between motivation, anxiety and depression

There are major differences in individuals’ motivated behaviour and stress coping responses....

Read time: 3 min

Satellite symposium

How to differentiate major depressive disorder from bipolar depression

Bipolar disorder is common, associated with a loss of 10–20 years of life, and frequently...

Read time: 3 min

Congress highlights

Is there a link between childhood adversity, mood disorders, and medical comorbidities?

New data presented at WCP21 suggest that maladaptive family function and immune dysregulation might...

Alzheimer's Disease

Read time: 2 min

Congress highlights

What’s happening in the brain in Alzheimer’s disease and dementia?

The brains of people with Alzheimer’s disease contain abnormal proteins—amyloid-beta...

Read time: 2 min

Satellite symposium

Anti-CGRP monoclonal antibodies in the real world

When are anti-CGRP monoclonal antibodies used for migraine in the real world, how effective are...

Read time: 3 min

Congress highlights

Does migraine alter COVID-19 susceptibility?

In a late-breaking abstract presentation at #AHSAM21, Professor Robert Shapiro, University of...

Read time: 3 min

Congress highlights

Pandemic requires comprehensive approach to mental health in the elderly

Existing psychiatric problems such as depression and anxiety in the elderly should not be forgotten...

Read time: 2 min

Congress highlights

To screen or not to screen in first-episode psychosis

There is no international consensus on whether or not to submit those experiencing first-episode...

Read time: 2 min

Congress highlights

Perspectives on the future of psychiatry: treatment and training

Prevention, prediction of outcome and precision in therapy emerged as themes at the EPA 2021...

Depression, Schizophrenia

Read time: 3 min

Congress highlights

Sleep quality, inflammation and early morning activity: all may influence mental health

Poor sleep is a modifiable risk factor linked to depression, schizophrenia, and chronic physical...

Read time: 3 min

Satellite symposium

Exploring the interplay between COVID-19 and major depressive disorder

The COVID-19 pandemic represents a ‘triple threat’, impacting not only the physical...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country